Measles Is Endemic Again as the U.S. Loses Its Elimination Status
A Pan American Health Organization commission stripped the U.S. of its measles-elimination status after the virus spread nonstop for more than a year, sources told NBC News. The designation, held since 2000, is gone as cases top 5,400 this year and ten people have died. PAHO is expected to make it official Tuesday.
- Original source: nbcnews.com.
- The source published it on Nov 17, 2026 at 12:41 AM.
- No second outlet has reported it yet. Treat it as a single-source claim.
An independent PAHO commission voted to revoke the United States' measles-elimination status after concluding the virus has circulated without interruption for over a year, according to sources familiar with the vote. The decision reverses a public health win the country first claimed in 2000 and puts measles back in the endemic column. PAHO, a branch of the World Health Organization, is expected to announce the move publicly on Tuesday.
The case count behind the ruling is brutal. More than 5,400 infections have been logged this year — the highest since 1991 and more than twice last year's total — and ten people have died, state health departments report. At least four of those deaths were infants too young to be vaccinated. Some health departments in outbreak zones now urge an early shot for babies as young as 6 months.
The commission spent four days deliberating in Washington, D.C., with eight public health experts weighing genetic data from homegrown cases to see whether outbreaks across states were connected, plus vaccination coverage, surveillance quality and the country's outbreak-response plans. Kindergarten vaccination sat at 92% for the 2025-26 school year, down from the 95% needed to block outbreaks in 2019-20. An NBC News investigation found 75% of counties and jurisdictions with data fall below that 95% mark, and 82% have reported declines since 2019. Catron County, New Mexico, and Adams and Custer counties in Idaho sit under 50%.
Noel Brewer, a public health professor at the University of North Carolina at Chapel Hill, framed the scale bluntly: the U.S. has recorded more measles cases in the last 18 months than in the previous 25 years combined. He called the absence of a national strategy “clear negligence.” Walter Orenstein, former director of the CDC's Immunization Program, warned that endemic measles endangers the unvaccinated — especially infants and immunocompromised people. “People can go into a supermarket and get infected,” he said.
An HHS spokesperson said the CDC has “mounted an aggressive response,” pointing to $100 million in extra funding allocated in October and experts sent to help states. CDC Director Dr. Erica Schwartz said losing the designation “doesn't mean we abandon an evidence-based approach.” Both she and Health Secretary Robert F. Kennedy Jr. still recommend MMR vaccination, the spokesperson said — even as Kennedy has questioned the shot's safety and pushed unproven remedies like inhaled steroids, and President Donald Trump falsely claimed in August that the combined measles vaccine could be “quite lethal.”
The U.S. isn't the first in the region to fall. Canada lost its status last year after an outbreak passed 5,000 cases, noted Jon Andrus, a George Washington University global health professor who chairs the PAHO commission. He said Canada's political leadership fought hard to hold elimination, calling that the sad part of its story. For the U.S., experts say, winning the designation back could take years.
TopicsPan American Health Organization · World Health Organization · CDC · Robert F. Kennedy Jr. · Erica Schwartz · Noel Brewer · Walter Orenstein · Jon Andrus
Source: nbcnews.com
Written by AI from verified reporting.
More stories
- Health & science finance.yahoo.com 0 viewsNovartis' Cosentyx wins FDA nod as first anti-IL-17 biologic for PMR
- Health & science casrai.org 0 viewsFDA greenlights giredestrant-everolimus duo for ESR1-mutated breast cancer
- Health & science aol.com 1 viewFDA Clears FoundationOne Liquid CDx as First Companion Test for WILSERDLY Combo
- Health & science statnews.com 1 viewFDA approves Roche's Wilserdly for resistant breast cancer

